REVIEW Nitrendipine is a racemic dihydropyridine calcium channel blocker for the treatment of primary hypertension.
REFERENCES
[1]
Meyer, Horst; Bossert, Friedrich; Vater, Wulf; Stoepel, Kurt Dialkyl 4-aryl-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylates Ger. Offen. (1972), DE 2117571 A 19721019.
[2]
Meyer, H.; Bossert, F.; Wehinger, E.; Stoepel, K.; Vater, W. Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions Arzneimittel-Forschung (1981), 31(3), 407-9.
[3]
Meyer, Horst; Bossert, Friedrich; Wehinger, Egbert; Scherling, Dietrich Chemistry of nitrendipine and its metabolites Edited by Scriabine, Alexander; Vanov, Svetislav; Deck, Klaus Nitrendipine (1984), 1-9.
[4]
Goa KL, Sorkin EM. Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs. 1987 Feb;33(2):123-55.
All products are stocked and shipped from the SF Bay, California, USA via FedEx, UPS or DHL.
All batches backed with full quality assurance.
??
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.
Add to Favorites 
Delete from Favorites 
